Is moist snuff use associated with excess risk of IHD or stroke? A longitudinal follow-up of snuff users in Sweden

Abstract

Background: The potential risks of Swedish moist snuff (snus) are debated and studies have shown diverging results. Aims: The aim of this study is to investigate whether there is any excess risk of ischaemic heart disease (IHD) and stroke from snuff use. Methods: The Swedish Survey of Living Conditions from 1988—89 was record-linked to the Swedish Cause of Death Register and the Swedish Hospital Discharge Register to investigate excess mortality and hospitalization from IHD and stroke. A Poisson regression model was used and incidence rate ratios (IRRs) for snuff and smoking were calculated controlling for age, physical activity, self-reported health, number of longstanding illnesses, residential area, and socioeconomic position. Results: Among snuff users there were no excess risks of mortality or hospitalization from IHD (IRR 0.8; 0.5—1.2,) or stroke (IRR 1.1; 0.7—1.8), but, as expected, clear excess risks were found for smokers (IRR 1.7; 1.4—2.1 for IHD, and IRR 1.4; 1.0—1.9 for stroke). Conclusions: This study has not shown any excess risk among users of snuff for IHD or stroke. If there is a risk associated with snuff it is evidently much lower than those associated with smoking.

Keywords

Tobacco moist snuff snus smoking IHD stroke

Get full access to this article

View all access options for this article.

References

Bostrom G. Chapter 9: Habits of life and health. In: Persson G, Danielsson M, Rosén M, et al, editors. Health in Sweden: The National Public Health Report 2005 . Scand J Public Health 2006;(Suppl 67):199—228.

Stegmayr B. , Eliasson M. , Rodu B. The decline of smoking in northern Sweden . Scand J Public Health 2005;33:321—4.

Editorial Commentary, Scand J Public Health 2005;33: 243.

Bolinder G. , Alfredsson L. , Englund A. , de Faire U. Smokeless tobacco use and increased cardiovascular mortality among Swedish construction workers. Am J Public Health 1994 ;84: 399—404.

Huhtasaari F. , Asplund K. , Lundberg V. , Stegmayr B. , Wester PO Tobacco and myocardial infarction: Is snuff less dangerous than cigarettes? BMJ 1992;305: 1252—6.

Huhtasaari F. , Lundberg V. , Eliasson M. , Janlert U. , Asplund K. Smokeless tobacco as a possible risk factor for myocardial infarction: A population-based study in middle-aged men. J Am Coll Cardiol 1999 ;34:1784— 90.

Asplund K. , Nasic S. , Janlert U. , Stegmayr B. Smokeless tobacco as a possible risk factor for stroke in men: A nested case-control study. Stroke 2003;34:1754—9.

Johansson S. , Sundquist K. , Qvist J. , Sundquist J. Smokeless tobacco and coronary heart disease: A 12-year follow-up study. Eur J Cardiovasc Prev Rehabil 2005;12:387—92.

Hergens MP , Ahlbom A. , Andersson T. , Pershagen G. Swedish moist snuff and myocardial infarction among men. Epidemiology 2005;16:12—16.

10.

Asplund K. Smokeless tobacco and cardiovascular disease . Prog Cardiovasc Dis 2003;45:383—94.

11.

Mehta MC , Jain AC , Mehta A. , Billie M. Cardiac arrhythmias following intravenous nicotine: Experimental study in dogs. J Cardiovasc Pharmacol Ther 1997;2:291—8.

12.

Lightwood JM , Glantz SA Short-term economic and health benefits of smoking cessation: Myocardial infarction and stroke. Circulation 1997;96:1089—96.

13.

Wennberg P. , Eliasson M. , Hallmans G. , Johansson L. , Boman K. , Jansson J-H. The risk of myocardial infarction and sudden cardiac death among snuff users with or without a previous history of smoking . J Intern Med. 2007; in press.